GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid.
|
|
Scooped by
Système de veille
onto ALIMENTATIONS November 17, 4:02 AM
|
Your new post is loading...